When heart disease affects people under age 50, it’s considered “early onset” and experts believe there’s a genetic link. Yale investigators have found that a particular gene is common to families with multiple members who either have early-onset heart...
Adults who take several prescription medications are more likely to experience serious falls, say Yale researchers and their co-authors in a new study. This heightened risk can affect middle-aged individuals — a population not typically viewed as...
Treatments for Parkinson’s disease have most recently focused on increasing dopamine, a chemical messenger in the brain that affects reward-based behaviors and motivation, as well as movement. A new study by Yale researchers challenges long-held...
In a new study, Yale researchers challenge a long-held assumption about how insulin-producing cells in the pancreas sense and respond to glucose. Their findings could lead to changes in the way that scientists approach the treatment of diabetes, the...
A tool developed by researchers at Yale, Stanford, and Bioethics International can promote greater sharing of clinical trial data by pharmaceutical companies. While nearly one-third of the companies that the researchers assessed met standards for sharing...
On June 25, Yale School of Medicine’s Dr. Jeanette Tetrault spoke at a convening of the President’s Opioid Commission and the Office of National Drug Control Policy. The purpose of the meeting was to discuss the steps needed to build a national addiction...
The National Clinician Scholars Program (NCSP) is an interprofessional fellowship program designed to prepare a select group of future clinician leaders through scholarship and action at the national, state, and local levels. On July 1, the NCSP at Yale...